{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:53:32Z","timestamp":1778640812409,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>GnRHa treatment was established for improving final adult height (FAH) in children presenting with Idiopathic central precocious puberty (ICPP) up to age 8, while several controversies remained for older age groups. The primary objective was to evaluate whether boys diagnosed with ICPP over 9\u2009years of chronological age (CA) could achieve a height benefit from GnRHa treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively evaluated the medical records of 23 boys treated for idiopathic central precocious puberty between January 2018 and January 2021 at Jiangsu Children\u2019s Medical Center. All patients started treatment with intramuscular depot GnRHa at a dose of 80\u2013100\u2009\u03bcg\/kg, followed by continuous intramuscular injection every 28\u2009days at a dose of 60\u201380\u2009\u03bcg\/kg. The hormonal parameters, bone age\/chronological age ratio, FAH, growth velocity (GV), tanner staging and body mass index (BMI) were assessed during the treatment period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After one course of treatment (3\u2009months), the basal FSH and testosterone levels were reduced, while the basal LH value was not significantly changed compared with those before treatment. Furthermore, the mean BA\/CA ratio reduction was statistically significant at month 12. The mean PAH following administration of GnRHa after 12\u2009months was statistically improved compared with those at baseline. In addition, the clinical sign of puberty and GV were significantly improved and the BMI remained unchanged as desired at month 12.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This analysis highlighted the positive outcome on the decrease in the rate of bone maturation, with a favorable effect on progression of clinical signs of puberty. Furthermore, our study confirmed PAH was improved even in the older children at onset of treatment (ages 9\u201310), emphasizing the importance of personalized treatment in such population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01207-z","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:29:09Z","timestamp":1669969749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9\u2009years: findings from a real-world retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Ming-ming","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"issue":"5","key":"1207_CR1","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/cen.14410","volume":"94","author":"X Luo","year":"2021","unstructured":"Luo X, Liang Y, Hou L, Wu W, Ying Y, Ye F. Long-term efficacy and safety of gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty: a systematic review and meta-analysis. Clin Endocrinol. 2021;94(5):786\u201396.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1207_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S2213-8587(15)00380-0","volume":"4","author":"AC Latronico","year":"2016","unstructured":"Latronico AC, Brito VN, Carel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol. 2016;4(3):265\u201374.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"27","key":"1207_CR3","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1097\/MD.0000000000000260","volume":"93","author":"P Li","year":"2014","unstructured":"Li P, Li Y, Yang CL. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis. Medicine (Baltimore). 2014;93(27):e260.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1207_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40272-015-0130-8","volume":"17","author":"M Chen","year":"2015","unstructured":"Chen M, Eugster EA. Central precocious puberty: update on diagnosis and treatment. Paediatr Drugs. 2015;17(4):273\u201381.","journal-title":"Paediatr Drugs"},{"issue":"10","key":"1207_CR5","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s00431-021-04022-1","volume":"180","author":"AV Cheuiche","year":"2021","unstructured":"Cheuiche AV, Da SL, de Paula L, Lucena I, Silveiro SP. Diagnosis and management of precocious sexual maturation: an updated review. Eur J Pediatr. 2021;180(10):3073\u201387.","journal-title":"Eur J Pediatr"},{"issue":"Suppl 1","key":"1207_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1472-6483(11)60210-1","volume":"5","author":"O Ortmann","year":"2002","unstructured":"Ortmann O, Weiss JM, Diedrich K. Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action. Reprod BioMed Online. 2002;5(Suppl 1):1\u20137.","journal-title":"Reprod BioMed Online"},{"issue":"Suppl 1","key":"1207_CR7","first-page":"723","volume":"13","author":"N Lahlou","year":"2000","unstructured":"Lahlou N, Carel JC, Chaussain JL, Roger M. Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab. 2000;13(Suppl 1):723\u201337.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"1207_CR8","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1210\/jc.2006-2479","volume":"92","author":"EA Eugster","year":"2007","unstructured":"Eugster EA, Clarke W, Kletter GB, Lee PA, Neely EK, Reiter EO, et al. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial. J Clin Endocrinol Metab. 2007;92(5):1697\u2013704.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1207_CR9","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/EJE-15-0590","volume":"174","author":"F Guaraldi","year":"2016","unstructured":"Guaraldi F, Beccuti G, Gori D, Ghizzoni L. Management of endocrine disease: long-term outcomes of the treatment of central precocious puberty. Eur J Endocrinol. 2016;174(3):R79\u201387.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1207_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000491103","volume":"90","author":"PB Kaplowitz","year":"2018","unstructured":"Kaplowitz PB, Backeljauw PF, Allen DB. Toward more targeted and cost-effective gonadotropin-releasing hormone analog treatment in girls with central precocious puberty. Horm Res Paediatr. 2018;90(1):1\u20137.","journal-title":"Horm Res Paediatr"},{"issue":"Suppl 1","key":"1207_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1515\/JPEM.2000.13.S1.765","volume":"13","author":"D Mul","year":"2000","unstructured":"Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van DWH, et al. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab. 2000;13(Suppl 1):765\u201372.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl 1","key":"1207_CR12","first-page":"747","volume":"13","author":"CJ Partsch","year":"2000","unstructured":"Partsch CJ, Heger S, Sippell WG. Treatment of central precocious puberty: lessons from a 15 years prospective trial. German Decapeptyl study group. J Pediatr Endocrinol Metab. 2000;13(Suppl 1):747\u201358.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"1207_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/humupd\/dmh012","volume":"10","author":"JC Carel","year":"2004","unstructured":"Carel JC, Lahlou N, Roger M, Chaussain JL. Precocious puberty and statural growth. Hum Reprod Update. 2004;10(2):135\u201347.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"1207_CR14","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1210\/jcem.84.6.5647","volume":"84","author":"JC Carel","year":"1999","unstructured":"Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, et al. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in precocious puberty. J Clin Endocrinol Metab. 1999;84(6):1973\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1207_CR15","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","volume":"86","author":"KO Klein","year":"2001","unstructured":"Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GJ. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab. 2001;86(10):4711\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"1207_CR16","first-page":"787","volume":"13","author":"M Micillo","year":"2000","unstructured":"Micillo M, Salerno M, Officioso A, Perna E, Gasparini N, Pisaturo L, et al. Near final height after GnRH agonist treatment in central precocious puberty. J Pediatr Endocrinol Metab. 2000;13(Suppl 1):787\u201390.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"1207_CR17","first-page":"418","volume":"48","author":"MA Hua-mei","year":"2010","unstructured":"Hua-mei MA. Testis volume, pubic hair development and spermarcheal age in urban Chinese boys. Zhonghua Er Ke Za Zhi. 2010;48(6):418\u201324.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"22","key":"1207_CR18","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1056\/NEJMcp0800459","volume":"358","author":"JC Carel","year":"2008","unstructured":"Carel JC, Leger J. Clinical practice. Precocious puberty. N Engl J Med. 2008;358(22):2366\u201377.","journal-title":"N Engl J Med"},{"issue":"235","key":"1207_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.44.235.291","volume":"44","author":"WA Marshall","year":"1969","unstructured":"Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44(235):291\u2013303.","journal-title":"Arch Dis Child"},{"key":"1207_CR20","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"WWPS Greulich","year":"1959","unstructured":"Greulich WWPS. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford: Stanford University Press; 1959.","edition":"2"},{"issue":"7","key":"1207_CR21","first-page":"487","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi. 2009;47(7):487\u201392.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"4","key":"1207_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0022-3476(52)80205-7","volume":"40","author":"N Bayley","year":"1952","unstructured":"Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952;40(4):423\u201341.","journal-title":"J Pediatr"},{"key":"1207_CR23","doi-asserted-by":"publisher","first-page":"713880","DOI":"10.3389\/fendo.2021.713880","volume":"12","author":"R Cao","year":"2021","unstructured":"Cao R, Liu J, Fu P, Zhou Y, Li Z, Liu P. The diagnostic utility of the basal luteinizing hormone level and single 60-minute post GnRH agonist stimulation test for idiopathic central precocious puberty in girls. Front Endocrinol (Lausanne). 2021;12:713880.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1207_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1687-9856-2013-20","volume":"2013","author":"EK Neely","year":"2013","unstructured":"Neely EK, Silverman LA, Geffner ME, Danoff TM, Gould E, Thornton PS. Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy. Int J Pediatr Endocrinol. 2013;2013(1):20.","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"1207_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4274\/jcrpe.galenos.2020.2020.0210","volume":"13","author":"S Schubert","year":"2021","unstructured":"Schubert S, Hvelplund AH, Handberg A, Hagstroem S, Leunbach TL. Elevated pre-injection basal luteinizing hormone concentrations are common in girls treated for central precocious puberty. J Clin Res Pediatr Endocrinol. 2021;13(2):204\u201311.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"3","key":"1207_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jpeds.2012.08.038","volume":"162","author":"KA Lewis","year":"2013","unstructured":"Lewis KA, Eugster EA. Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty. J Pediatr. 2013;162(3):562\u20135.","journal-title":"J Pediatr"},{"issue":"3","key":"1207_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.6065\/apem.1938176.088","volume":"25","author":"KI Lim","year":"2020","unstructured":"Lim KI, Lee HS, Hwang JS. Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy. Ann Pediatr Endocrinol Metab. 2020;25(3):169\u201373.","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"1207_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13633-016-0033-7","volume":"2016","author":"AJ Arcari","year":"2016","unstructured":"Arcari AJ, Gryngarten MG, Freire AV, Ballerini MG, Ropelato MG, Bergada I, et al. Body mass index in girls with idiopathic central precocious puberty during and after treatment with GnRH analogues. Int J Pediatr Endocrinol. 2016;2016:15.","journal-title":"Int J Pediatr Endocrinol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01207-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01207-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01207-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:30:28Z","timestamp":1669969828000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01207-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01207-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"assertion":[{"value":"23 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were in accordance with the Declaration of Helsinki. This study was approved by the Ethics Committee of the Children\u2019s Hospital of Nanjing Medical University. And the need for informed consent was waived by Ethics Committee of the Children\u2019s Hospital of Nanjing Medical University, because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}